Skip to content
OpenCapital
Get started

BlackSky Technology BKSY Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
Photronics logo
PhotronicsPLAB
$3.9M+43.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.19M-50.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%
BlackSky Technology logo
BlackSky TechnologyBKSY
$8.38M-29.4%

Other financials

Income statement

See full
Revenue$20.8M-29.7%
Operating income-$18.5M-54.7%
Net income-$29.7M-132%
EPS (diluted)-$0.82-95.2%

Balance sheet

See full
Cash & equivalents$41.4M+89.1%
Total debt$226.7M+76.9%
Total equity$80.8M-9.1%
Total assets$371.7M+30.5%

Cash flow

See full
Operating cash flow-$2.4M-109%
CapEx$3.9M-13.4%
Free cash flow-$6.2M-127%

Valuation

See full
Market cap$935.52M+110%
Enterprise value$1.12B+103%
P/S9.6×+5.4×

Profitability

See full
Operating margin-54.7%+31.4pp
Net margin-89.1%+289pp
FCF margin-75.2%-82.5pp

Returns & leverage

See full
Return on equity-102.7%+164pp
Debt / equity2.8×+1.4×
Current ratio3.5×-0.3×

Where this comes from

Reported directly by BlackSky Technology in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: BlackSky Technology’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about BlackSky Technology's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BlackSky Technology's indefinite-lived research and development assets?
BlackSky Technology (BKSY) reported indefinite-lived research and development assets of $8.38M in Q4 2025.
How has BlackSky Technology's indefinite-lived research and development assets changed year-over-year?
BlackSky Technology's indefinite-lived research and development assets decreased by 29.4% year-over-year, from $11.87M to $8.38M.
What does indefinite-lived research and development assets mean?
These represent the value of acquired in-process research and development projects that have not yet reached commercial viability. Because these assets do not have a defined useful life, they are not amortized but are instead subject to periodic impairment testing. This metric reflects the company's investment in future technological capabilities and long-term innovation potential.